Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share, Trends, Industry Analysis Report – By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, and Others), By Product Type, By Stage of Development, By

Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share, Trends, Industry Analysis Report – By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, and Others), By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2024–2032



The cell & gene therapy bioanalytical testing services market size is expected to reach USD 950.06 million by 2032, according to a new study by Polaris Market Research. The report “Cell & Gene Therapy Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report – By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, and Others), By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2023–2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing number of studies revealing the ability of cell and gene therapies to treat multiple diseases is driving investments in research activities in the healthcare industry. The government funding to increase its capacity to test medication and healthcare equipment in the marketplace. For instance, in March 2023, the UK government announced a grant of USD 10 million for the National Health Service Blood and Transplant (NHSBT) to open a new facility called the Clinical Biotechnology Centre (CBC) for the development and manufacturing of new cell and gene therapies. Furthermore, the growing number of cancer cases across the world is significantly emphasizing countries to invest in cell and gene therapy research. The most populous nations, such as India and China, are launching new therapies for the cancer treatment. For instance, in April 2024, Tata Memorial Centre & Indian Institute of Technology (IIT), Bombay launched India’s first developed CAR-T cell therapy for cancer treatment. Thus new cell therapy is boosting demand for cell & gene therapy bioanalytical testing services, which is contributing to market growth.

The rising pharmaceutical companies' initiatives to increase investments in the design and production of cell and gene therapies are driving the demand for performance-evaluating tools and services, which is positively influencing the global market. For instance, in February 2024, Azzur Group announced the new offering of analytical laboratory testing services as a part of developing cell and gene therapy. This is specifically to test advanced therapeutics and other medical products. The increasing prevalence of chronic diseases is encouraging researchers to innovate effective medications. The growing development of cell and gene therapies effectively performs in treating health issues among the population. According to the Food and Drug Administration (FDA), ∼100,000 people are suffering from sickle cell disease. This contributed to the design of new therapies around the world. In December 2023, the US FDA announced approval for two gene therapies—Lyfgenia & Casgevy—for the treatment of sickle cell disease.

Cell & Gene Therapy Bioanalytical Testing Services Market Report Highlights
  • The bioavailability & bioequivalence studies segment, by test type is anticipated to witness the highest growth rate during the forecast period due to rising drug innovation activities.
  • In terms of product type, the cell therapy segment accounted for the largest market share in 2023, owing to the increasing production of cell therapies for several diseases.
  • APAC is projected to register the highest growth during the forecast period, attributable to the growing investments in the biotechnological industry.
  • Europe is expected to register a significant CAGR in the cell & gene therapy bioanalytical testing services market during the forecast period due to due increased investment in advanced therapeutic research.
  • BioAgilytix Labs, Charles River Laboratories, Intertek Group, IQVIA, KCAS Bioanalytical Services, and Pharmaron are among the global market players.
Polaris Market Research has segmented the cell & gene therapy bioanalytical testing services market report on the basis of test type, product type, stage of development, indication, and region:

By Test Type Outlook (Revenue – USD million, 2019–2032)
  • Bioavailability & Bioequivalence Studies
  • Pharmacokinetics
  • Pharmacodynamics
  • Others
By Product Type Outlook (Revenue – USD million, 2019–2032)
  • Gene Therapy
  • Gene-Modified Cell Therapy
  • Cell Therapy
By Stage of Development Outlook (Revenue – USD million, 2019–2032)
  • Nonclinical
  • Clinical
By Indication Outlook (Revenue – USD million, 2019–2032)
  • Oncology
  • Infectious Diseases
  • Neurological Disorders
  • Rare Diseases
  • Others
By Regional Outlook (Revenue – USD million, 2019–2032)
  • North America
- US

- Canada
  • Europe
- Germany

- UK

- France

- Italy

- Spain

- Russia

- Netherlands
  • Asia Pacific
- China

- India

- Japan

- South Korea

- Indonesia

- Malaysia
  • Latin America
- Argentina

- Brazil

- Mexico
  • Middle East & Africa
- UAE

- Saudi Arabia

- Israel

- South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Insights
4.1. Cell & Gene Therapy Bioanalytical Testing Services Market – Application Snapshot
4.2. Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Investments in Cell and Gene Therapy Developments Drive the Market Growth
4.2.1.2. Growing Development of Cell and Gene Therapies Drives Market Growth
4.2.2. Restraints and Challenges
4.2.2.1. Stringent Regulations Hinders the Market Growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cell & Gene Therapy Bioanalytical Testing Services Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
5.3. Bioavailability & Bioequivalence Studies
5.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Bioavailability & Bioequivalence Studies, by Region, 2019-2032 (USD Million)
5.4. Pharmacokinetics
5.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacokinetics, by Region, 2019-2032 (USD Million)
5.5. Pharmacodynamics
5.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacodynamics, by Region, 2019-2032 (USD Million)
5.6. Others
5.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
6.3. Gene Therapy
6.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene Therapy, by Region, 2019-2032 (USD Million)
6.4. Gene-Modified Cell Therapy
6.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene-Modified Cell Therapy, by Region, 2019-2032 (USD Million)
6.5. Cell Therapy
6.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Cell Therapy, by Region, 2019-2032 (USD Million)
7. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development
7.1. Key Findings
7.2. Introduction
7.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
7.3. Nonclinical
7.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Nonclinical, by Region, 2019-2032 (USD Million)
7.4. Clinical
7.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Clinical, by Region, 2019-2032 (USD Million)
8. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication
8.1. Key Findings
8.2. Introduction
8.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
8.3. Infectious Diseases
8.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
8.4. Neurological disorders
8.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Neurological disorders, by Region, 2019-2032 (USD Million)
8.5. Oncology
8.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Oncology, by Region, 2019-2032 (USD Million)
8.6. Rare Diseases
8.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Rare Diseases, by Region, 2019-2032 (USD Million)
8.7. Others
8.7.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)
9. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Geography
9.1. Key Findings
9.2. Introduction
9.2.1. Cell & Gene Therapy Bioanalytical Testing Services Market Assessment, By Geography, 2019-2032 (USD Million)
9.3. Cell & Gene Therapy Bioanalytical Testing Services Market – North America
9.3.1. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.3.2. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.3.3. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.3.4. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.3.5. Cell & Gene Therapy Bioanalytical Testing Services Market – U.S.
9.3.5.1. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.3.5.2. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.3.5.3. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.3.5.4. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.3.6. Cell & Gene Therapy Bioanalytical Testing Services Market – Canada
9.3.6.1. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.3.6.2. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.3.6.3. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.3.6.4. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4. Cell & Gene Therapy Bioanalytical Testing Services Market – Europe
9.4.1. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.2. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.3. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.4. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.5. Cell & Gene Therapy Bioanalytical Testing Services Market – UK
9.4.5.1. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.5.2. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.5.3. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.5.4. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.6. Cell & Gene Therapy Bioanalytical Testing Services Market – France
9.4.6.1. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.6.2. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.6.3. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.6.4. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.7. Cell & Gene Therapy Bioanalytical Testing Services Market – Germany
9.4.7.1. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.7.2. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.7.3. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.7.4. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.8. Cell & Gene Therapy Bioanalytical Testing Services Market – Italy
9.4.8.1. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.8.2. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.8.3. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.8.4. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.9. Cell & Gene Therapy Bioanalytical Testing Services Market – Spain
9.4.9.1. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.9.2. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.9.3. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.9.4. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.10. Cell & Gene Therapy Bioanalytical Testing Services Market – Netherlands
9.4.10.1. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.10.2. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.10.3. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.10.4. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.11. Cell & Gene Therapy Bioanalytical Testing Services Market – Russia
9.4.11.1. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.11.2. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.11.3. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.11.4. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.4.12. Cell & Gene Therapy Bioanalytical Testing Services Market – Rest of Europe
9.4.12.1. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.4.12.2. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.4.12.3. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.4.12.4. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5. Cell & Gene Therapy Bioanalytical Testing Services Market – Asia Pacific
9.5.1. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.2. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.3. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.4. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.5. Cell & Gene Therapy Bioanalytical Testing Services Market – China
9.5.5.1. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.5.2. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.5.3. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.5.4. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.6. Cell & Gene Therapy Bioanalytical Testing Services Market – India
9.5.6.1. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.6.2. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.6.3. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.6.4. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.7. Cell & Gene Therapy Bioanalytical Testing Services Market – Malaysia
9.5.7.1. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.7.2. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.7.3. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.7.4. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.8. Cell & Gene Therapy Bioanalytical Testing Services Market – Japan
9.5.8.1. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.8.2. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.8.3. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.8.4. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.9. Cell & Gene Therapy Bioanalytical Testing Services Market – Indonesia
9.5.9.1. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.9.2. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.9.3. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.9.4. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.10. Cell & Gene Therapy Bioanalytical Testing Services Market – South Korea
9.5.10.1. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.10.2. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.10.3. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.10.4. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.11. Cell & Gene Therapy Bioanalytical Testing Services Market – Australia
9.5.11.1. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.11.2. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.11.3. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.11.4. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.5.12. Cell & Gene Therapy Bioanalytical Testing Services Market – Rest of Asia Pacific
9.5.12.1. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.5.12.2. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.5.12.3. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.5.12.4. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.6. Cell & Gene Therapy Bioanalytical Testing Services Market – Middle East & Africa
9.6.1. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.6.2. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.6.3. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.6.4. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.6.5. Cell & Gene Therapy Bioanalytical Testing Services Market – Saudi Arabia
9.6.5.1. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.6.5.2. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.6.5.3. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.6.5.4. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.6.6. Cell & Gene Therapy Bioanalytical Testing Services Market – UAE
9.6.6.1. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.6.6.2. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.6.6.3. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.6.6.4. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.6.7. Cell & Gene Therapy Bioanalytical Testing Services Market – Israel
9.6.7.1. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.6.7.2. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.6.7.3. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.6.7.4. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.6.8. Cell & Gene Therapy Bioanalytical Testing Services Market – South Africa
9.6.8.1. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.6.8.2. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.6.8.3. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.6.8.4. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.6.9. Cell & Gene Therapy Bioanalytical Testing Services Market – Rest of Middle East & Africa
9.6.9.1. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.6.9.2. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.6.9.3. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.6.9.4. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.7. Cell & Gene Therapy Bioanalytical Testing Services Market – Latin America
9.7.1. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.7.2. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.7.3. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.7.4. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.7.5. Cell & Gene Therapy Bioanalytical Testing Services Market – Mexico
9.7.5.1. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.7.5.2. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.7.5.3. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.7.5.4. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.7.6. Cell & Gene Therapy Bioanalytical Testing Services Market – Brazil
9.7.6.1. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.7.6.2. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.7.6.3. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.7.6.4. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.7.7. Cell & Gene Therapy Bioanalytical Testing Services Market – Argentina
9.7.7.1. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.7.7.2. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.7.7.3. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.7.7.4. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
9.7.8. Cell & Gene Therapy Bioanalytical Testing Services Market – Rest of Latin America
9.7.8.1. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
9.7.8.2. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
9.7.8.3. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
9.7.8.4. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. BioAgilytix Labs
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Charles River Laboratories
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Intertek Group Plc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. IQVIA, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. KCAS Bioanalytical Services
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Laboratory Corporation of America Holdings
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Pharmaron
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Pharmaceutical Product Development, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Prolytix
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. SGS SA
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Syneos Health
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings